Merit Medical Names Martha Aronson as President and Chief Executive Officer

July 7, 2025—Merit Medical Systems, Inc. announced the appointment of Martha Aronson as the company’s President and Chief Executive Officer (CEO), effective October 3, 2025.

The company’s founder, Fred P. Lampropoulos, will remain as Chairman of the Board, President, and CEO of Merit through October 3. Upon Aronson’s appointment, Lampropoulos will continue to serve as Chairman of the Board, advised the company.

According to Merit Medical, Aronson’s experience includes overseeing global health care businesses ranging in size from $500 million to $1 billion.

As summarized in the company’s press release, Aronson was the Executive Vice President and President of Global Healthcare for Ecolab, Inc. and served as the Senior Vice President and President—North America for Hill-Rom Holdings, Inc. Before that, she spent nearly 20 years at Medtronic in various general management and leadership roles in the United States and internationally.

Additionally, Aronson guided and advised companies as a board director, most recently serving as a director, and formerly as Chair of the Board, for ConMed Corporation. She also served as a director of Methode Electronics, Inc; Clinical Innovations, LLC; Cardiovascular Systems, Inc.; Beta Bionics, Inc.; Hutchinson Technology, Inc.; Bright Uro; and OmCare.

“I am excited to join Merit and truly honored to take on this role,” commented Aronson in the company’s press release. “Fred has built and grown an extraordinary company over the past four decades, starting with one single idea and building it into the incredibly successful global company that it is today. Working with the talented team at Merit, I look forward to building upon his remarkable legacy and leading the company into a future of continued excellence and innovation.”